These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8052965)

  • 41. Dermatan sulfate anticoagulation: future replacement for heparin?
    Gravlee GP
    J Cardiothorac Vasc Anesth; 1995 Jun; 9(3):237-9. PubMed ID: 7669955
    [No Abstract]   [Full Text] [Related]  

  • 42. Monitoring of intraoperative heparinization in vascular surgery.
    Manny J; Romanoff H; Hyam E; Manny N
    Surgery; 1976 Nov; 80(5):641-3. PubMed ID: 982283
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anticoagulation With an Inhibitor of Factors XIa and XIIa During Cardiopulmonary Bypass.
    Pireaux V; Tassignon J; Demoulin S; Derochette S; Borenstein N; Ente A; Fiette L; Douxfils J; Lancellotti P; Guyaux M; Godfroid E
    J Am Coll Cardiol; 2019 Oct; 74(17):2178-2189. PubMed ID: 31648711
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antithrombotic properties of dermatan sulphate in a rat venous thrombosis model.
    Maggi A; Abbadini M; Pagella PG; Borowska A; Pangrazzi J; Donati MB
    Haemostasis; 1987; 17(6):329-35. PubMed ID: 3428718
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Evaluation of the adequacy of heparin administration during hemosorption].
    Iunovidova LI; Lekhtman AM; Levantovskaia OM
    Khirurgiia (Mosk); 1990 Jun; (6):85-8. PubMed ID: 2214584
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dermatan sulphate in haemodialysis.
    Lane DA; Ryan K; Ireland H; Curtis JR; Nurmohamed MT; Krediet RT; Roggekamp MC; Stevens P; ten Cate JW
    Lancet; 1992 Feb; 339(8789):334-5. PubMed ID: 1346414
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of ultrafiltration with cardiopulmonary bypass on the removal of dabigatran from the circulation of adult pigs.
    DeNino WF; Carter CB; Sievert A; Goss A; Toole JM; Mukherjee R; Uber WE
    Perfusion; 2016 Jul; 31(5):424-30. PubMed ID: 26519741
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of a low molecular weight heparin as an anticoagulant in a model of cardiopulmonary bypass surgery.
    Koza MJ; Messmore HL; Wallock ME; Walenga JM; Pifarre R
    Thromb Res; 1993 Apr; 70(1):67-76. PubMed ID: 8390111
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monitoring of hemostasis in cardiac surgical patients: impact of point-of-care testing on blood loss and transfusion outcomes.
    Despotis GJ; Joist JH; Goodnough LT
    Clin Chem; 1997 Sep; 43(9):1684-96. PubMed ID: 9299961
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anticoagulation management during cross-clamping and bypass.
    Lander H; Zammert M; FitzGerald D
    Best Pract Res Clin Anaesthesiol; 2016 Sep; 30(3):359-70. PubMed ID: 27650345
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antithrombin-heparin covalent complex reduces microemboli during cardiopulmonary bypass in a pig model.
    Klement P; Berry LR; Liao P; Wood H; Tressel P; Smith LJ; Haque N; Weitz JI; Hirsh J; Paredes N; Chan AK
    Blood; 2010 Dec; 116(25):5716-23. PubMed ID: 20817849
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pilot study of the efficacy of a thrombin inhibitor for use during cardiopulmonary bypass.
    DeAnda A; Coutre SE; Moon MR; Vial CM; Griffin LC; Law VS; Komeda M; Leung LL; Miller DC
    Ann Thorac Surg; 1994 Aug; 58(2):344-50. PubMed ID: 8067830
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protamine sulphate inhibits pentasaccharide (SR80027)-induced bleeding without affecting its antithrombotic and anti-factor Xa activity in the rat.
    Bernat A; Herbert JM
    Haemostasis; 1996; 26(4):195-202. PubMed ID: 8872130
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiopulmonary bypass pumps and thrombin generation: what goes around comes around.
    Brister SJ; Pelletier A; Fedorshyn J; Puchalski S; Buchanan MR
    ASAIO J; 1998; 44(6):794-8. PubMed ID: 9831087
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assembly of the Heparin Removal Device for patients with suspected adverse reaction to protamine sulphate.
    Jegger D; Tevaerai HT; Horisberger J; Mueller XM; Seigneuil I; Pierrel N; Boone Y; von Segesser LK
    Perfusion; 2000 Sep; 15(5):453-6. PubMed ID: 11001169
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Normalizing Anti-Thrombin III for heparin management during routine cardiopulmonary bypass for congenital cardiothoracic surgery: A single institution practice review.
    Deptula J; Olshove V; Oldeen M; Kozik D; Alsoufi B
    Perfusion; 2024 Mar; ():2676591241239819. PubMed ID: 38503431
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ancrod (Arvin) as an alternative to heparin anticoagulation for cardiopulmonary bypass.
    Zulys VJ; Teasdale SJ; Michel ER; Skala RA; Keating SE; Viger JR; Glynn MF
    Anesthesiology; 1989 Dec; 71(6):870-7. PubMed ID: 2589675
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of heparin reversal and fresh platelet transfusion on platelet emboli post-cardiopulmonary bypass in a pig model.
    Dewanjee MK; Wu SM; Hsu LC
    ASAIO J; 2000; 46(3):313-8. PubMed ID: 10826743
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antithrombotic activity, bleeding effect and pharmacodynamics of a succinyl derivative of dermatan sulphate in rabbits.
    Saivin S; Caranobe C; Petitou M; Sie P; Lormeau JC; Level M; Crepon B; Houin G; Boneu B
    Br J Haematol; 1992 Apr; 80(4):509-13. PubMed ID: 1581235
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A randomized study of beef lung and pork mucosal heparin in cardiac surgery.
    Fiser WP; Read RC; Wright FE; Vecchio TJ
    Ann Thorac Surg; 1983 Jun; 35(6):615-20. PubMed ID: 6344819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.